Aftertrade Broking Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 13(4), 14(3) and 15(2) of Securities and Exchange ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.7 pts less than Nifty Microcap 250 and 5.3 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
A group of five acquirers (Arvind Karsandas Bhanushali and family members) along with one person acting in concert (PAC) have made a mandatory open offer to public shareholders of Aspira Pathlab & Diagnostics Ltd to buy up to 26,76,180 equity shares (26% of voting capital) at Rs.55 per share, totaling a maximum payout of about Rs.14.72 crore. The offer is triggered under SEBI Takeover Regulations due to an underlying acquisition that will take the acquirers' combined holding from 23.82% to 49.82% post-completion. The acquirers are existing promoters and their relatives, indicating a consolidation of promoter family control rather than a third-party takeover. Tendering period is scheduled from November 24, 2025 to December 5, 2025.
Public shareholders can tender their shares at Rs.55 each during the tendering window. This is essentially a family-driven consolidation with no change planned in the existing diagnostics business, and no competing offer has been announced.